OncologyMetabolic Bone Disease

Fibrous Dysplasia - McCune-Albright Syndrome

Oncology
Intermediate
6 min
High Yield
fibrous dysplasiaMcCune-Albright syndromeGNAS mutationshepherd's crook deformityground-glass appearanceprecocious pubertybisphosphonatesmalignant transformation
6:00
Start the timer to simulate exam conditions

CIM Case: Fibrous Dysplasia - McCune-Albright Syndrome

Clinical Scenario

Patient: 15-year-old female Presentation: Bilateral hip pain and progressive waddling gait over 2 years, worsening with activity Relevant history: Reached menarche at age 8 (precocious puberty), multiple café-au-lait spots noticed since infancy, previous pathological fracture of left femur at age 10, no family history Examination findings:

  • Multiple cafĂ©-au-lait spots with irregular "coast of Maine" borders
  • Bilateral coxa vara deformity with limited hip internal rotation
  • Shortened limbs (5cm LLD, left shorter)
  • Waddling gait with positive Trendelenburg bilaterally
  • Tenderness over proximal femora
  • No lymphadenopathy or masses
  • Thyroid not enlarged
  • Tanner stage 5 (early development)

Investigations Provided

Laboratory Results

TestResultNormal RangeInterpretation
Haemoglobin128 g/L115-145Normal
WCC6.8 x 10âč/L4-11Normal
Calcium2.35 mmol/L2.15-2.55Normal
Phosphate0.65 mmol/L0.8-1.5LOW
ALP420 U/L40-150Elevated
PTH4.5 pmol/L1.5-6.5Normal
25-OH Vitamin D75 nmol/L>50Normal
TSH0.3 mU/L0.4-4.0Low-normal
Free T422 pmol/L10-20High-normal
IGF-1450 ng/mL200-600Normal
FGF23180 RU/mL<100Elevated

Imaging

Image 1: Pelvis and Bilateral Hip X-rays

Radiological features:

  • Bilateral "shepherd's crook" deformity of proximal femora
  • Coxa vara (neck-shaft angle 90° bilaterally)
  • Ground-glass matrix throughout proximal femora
  • Expansile lesions with smooth endosteal scalloping
  • Previous healed fracture left femoral shaft with varus malunion
  • Acetabula appear involved
  • No aggressive periosteal reaction

Image 2: Whole Body Bone Scan

Findings:

  • Increased uptake in bilateral proximal femora
  • Increased uptake in skull base, left humerus, multiple ribs
  • Pattern consistent with polyostotic fibrous dysplasia

Image 3: CT Skull

Findings:

  • Extensive fibrous dysplasia of skull base
  • Sphenoid bone involvement
  • No optic canal encroachment currently
  • Ground-glass appearance typical

Questions & Model Answers

Q

What is the diagnosis and what endocrine abnormalities may be present?

Q

How do you manage the shepherd's crook deformity?

Q

What is the risk of malignant transformation?

Q

What are the imaging characteristics of fibrous dysplasia?

Q

What is the histopathology and how does it differ from other lesions?

Q

How would you manage skull base involvement and what are the ophthalmological concerns?


Key Teaching Points

Pattern Recognition

This pattern suggests McCune-Albright Syndrome:

  • Polyostotic fibrous dysplasia
  • CafĂ©-au-lait spots with "coast of Maine" borders
  • Precocious puberty (especially in females)
  • Endocrine abnormalities
  • Ground-glass appearance on X-ray
  • Shepherd's crook deformity

Distinguish from Other Conditions:

FeatureMcCune-AlbrightNeurofibromatosisMonostotic FD
Café-au-lait bordersIrregular (Maine)Smooth (California)None
Bone lesionsPolyostoticRare osseousSingle
EndocrineCommonNoNo
InheritanceSomatic mosaicAutosomal dominantSporadic

Critical Management Points

  1. Coast of Maine (irregular) borders - distinguishes from NF1
  2. Screen for multiple endocrinopathies - thyroid, GH, adrenal
  3. Hypophosphataemia is FGF23-mediated - treat with phosphate + calcitriol
  4. Bisphosphonates reduce pain - but don't prevent deformity
  5. Use IM nails, not plates - plates create stress risers
  6. Malignant transformation risk is 4-6% - radiation is contraindicated
  7. Optic nerve surveillance - essential in craniofacial involvement

Common Examiner Follow-ups

Q: "What is the role of burosumab in McCune-Albright syndrome?"

Burosumab is an anti-FGF23 monoclonal antibody:

  • Approved for X-linked hypophosphataemia
  • Being studied in FD/MAS-related hypophosphataemia
  • Normalises phosphate without high-dose supplements
  • May improve bone mineralisation
  • Currently off-label for MAS
  • Emerging evidence is promising

Q: "What is the Mazabraud syndrome?"

Mazabraud syndrome is the association of:

  • Fibrous dysplasia (usually polyostotic)
  • Intramuscular myxomas (soft tissue masses)
  • Rare, <100 cases reported
  • Myxomas are benign but can be mistaken for malignancy
  • Same GNAS mutation as McCune-Albright
  • No endocrine abnormalities

Q: "When would you biopsy a fibrous dysplasia lesion?"

Biopsy indications:

  • Atypical imaging features
  • Suspicion of malignant transformation
  • Diagnostic uncertainty
  • New pain in established lesion
  • Aggressive periosteal reaction
  • Soft tissue mass

Routine biopsy of classic-appearing FD is NOT required.


  • Monostotic Fibrous Dysplasia
  • Bone Tumours in Children
  • Pathological Fractures
  • Hypophosphataemic Rickets
  • Paediatric Endocrinology
  • Craniofacial Surgery